Sunday, September 13, 2026

Sam Chun Dang Pharm Signs 100 Million USD Licensing Deal for Oral Generics of Rybelsus and Wegovy

Sam Chun Dang Pharm secures a U.S. licensing deal for generic diabetes and obesity medications, valued at $100 million.

Exploring the Impacts of Kim Dae-sik’s U.S. Visit: What It Means for Korea’s National Interests

Kim Dae-sik discusses Jang Dong-hyuk's U.S. visit, emphasizing its importance for U.S.-South Korea relations despite mixed results.

Lewis Nash Trio’s Tribute to Oscar Peterson: What to Expect from This Exclusive Concert

Lewis Nash Trio pays tribute to Oscar Peterson with concerts in Seoul and Daegu, featuring hits from his classic albums.

Tag: industry

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Navigating FDA Challenges: How SK Biopharmaceuticals Plans to Move Forward with Opacalim

SK Biopharm will maintain its development and commercialization plans for epilepsy drug candidate Opacalim despite FDA's partial clinical hold.

Korean Obesity Drug Set to Launch Next Month as Hanmi’s Efe Targets Market

Hanmi Pharmaceutical plans to launch its domestically developed GLP-1 obesity drug Efe as early as next month, with Korean clinical data, safety and domestic production as key selling points.

SK Biopharm’s Bold Move: How MD Expertise is Shaping Global Drug Development in 2026

SK Biopharm is enhancing its global competitiveness in drug development by establishing a specialized R&D system for new drug candidates.

Humedics Targets Southeast Asian Aesthetic Market With Participation in Thai Medical Aesthetics Conference

Humedics showcased its hyaluronic acid filler Elravie Premier at ASLS Bangkok 2026 and highlighted clinical experience and treatment techniques to expand its presence in Thailand and Southeast Asia.

Hyundai’s 5.8 Billion USD Louisiana Steel Plant: What It Means for the Future of EV Manufacturing

A large banner reading HYUNDAI-POSCO LOUISIANA STEEL welcomes visitors, with two cranes lifting high between them.

How Samsung’s 256MB DRAM Revolutionized the Semiconductor Industry in 1994

On August 29, 1994, Samsung announced the successful development of the world's first 256MB DRAM at its Giheung research facility.

Daewoong Pharmaceutical Wins Seoul Biohealth Award: How Open Innovation is Transforming R&D in 2026

Daewoong Pharmaceutical received recognition for its R&D and open innovation collaboration at the 1st Seoul Biohealth Awards.

EverEx’s MORA Solutions: Revolutionizing Musculoskeletal Care with AI in 2026

EverEx, a digital healthcare company, accelerates expansion with strategic investments from domestic pharma and tech firms.

SK Biopharmaceuticals Acquires Opacalim: What This 795 Million USD Epilepsy Drug Deal Means for Patients

SK Biopharmaceuticals has acquired a new epilepsy drug candidate from Biohaven Bioscience, enhancing its portfolio in neurology.

K-Beauty Revolution: How Korean Medical Aesthetic Devices Are Dominating Global Markets

South Korea's skin beauty medical device companies are continuing to grow, focusing on the overseas market.

HLB Group’s New Cancer Drug Lirapegrafinib: What to Expect from FDA Approval on September 25?

HLB Group's drug development business is set to achieve key clinical and approval milestones in the second half of this year.

LG Chem Unveils Advanced Semiconductor Solutions at SEMICON Taiwan 2026: What to Expect?

LG Chem joins SEMICON Taiwan 2026 to secure semiconductor clients and expand business collaborations.

How K-Ramen Brands Are Boosting Global Sales with Samsung and LG Talent

South Korean ramen companies are hiring talent from Samsung and LG to boost global operations amid rising demand for K-Ramen.

Samsung vs Apple: Who Will Dominate the Smartphone Market in 2026?

Samsung's smartphone shipments are projected to rise by 0.8% this year, securing its position as the global market leader.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.